Grace Therapeutics, Inc. (NASDAQ:GRCE) Financings

Grace Therapeutics, Inc.

Financings

RaiseDate
Private placement of private placement financing
Update: about US$10M · US$2.1 a share · Craig-Hallum
Dealers: Craig-Hallum (lead)
Use of proceeds: Support the manufacturing and regulatory work needed to advance GTx-104
Aug 13, 2026
Warrant exercise of common stock on exercise of common warrants
Closed: US$4M raised · US$3.003 a share
Oct 23, 2025
Private placement of securities with accompanying warrants
Closed: US$15M raised
Buyers: Nantahala Capital (co-led the financing); ADAR1 Partners, LP (co-led the financing); Stonepine Capital Management
Use of proceeds: Pre-commercial planning, commercial team build out and product launch of GTx-104 if approved
Feb 13, 2025

Read by 6ix AI from the company's releases